Baloxavir Marboxil

Category: Antiviral



Baloxavir Marboxil Overview

Baloxavir marboxil (trade name Xofluza) is an antiviral medication for treatment of influenza A and influenza B FDA-approved in October 2018 and given as a single dose by mouth. It may reduce the duration of flu symptoms by about a day. It was developed by Shionogi Co., a Japanese pharmaceutical company, and Roche AG.[1] Contents 1 Pharmacodynamics 2 Side effects 3 Approval 4 References Pharmacodynamics Baloxavir marboxil is an influenza therapeutic agent (cap-depende...

Read more Baloxavir Marboxil Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Baloxavir_marboxil

Recent Baloxavir Marboxil Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Baloxavir Marboxil
  • Tablet: 20mg, 40mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Baloxavir Marboxil or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA